GlassScriptPhysician profile
Taras Mahlay
NPI 1285727164
$1,682.33
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $373 · 2022: $14.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $227.85 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $198.61 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $168.57 | 2019-2020 | |
| Lilly USA, LLC | $162.25 | 2019-2020 | |
| Amgen INC. | $148.26 | 2019-2020 | |
| Abbvie INC. | $132.73 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.46 | 2019 | |
| Pfizer INC. | $75.78 | 2019-2022 | |
| Amarin Pharma, INC. | $73.00 | 2019-2020 | |
| Abbott Laboratories | $70.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $55.53 | 2019-2020 | |
| Mannkind Corporation | $53.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.11 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.01 | 2019 | |
| Merck Sharp & Dohme LLC | $25.08 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $23.23 | 2019 | |
| Radius Health, INC. | $16.88 | 2019 | |
| Sanofi Pasteur INC. | $16.49 | 2019 | |
| Valeritas, INC. | $14.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.13 | 2020 | |
| Horizon Therapeutics Plc | $13.41 | 2019 | |
| Ibsa Pharma INC. | $13.32 | 2020 | |
| Endo Pharmaceuticals INC. | $11.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taras Mahlay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.